Related Experiment Video
Updated: May 16, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Severe lactose intolerance in a patient with coronary artery disease and ischemic cardiomyopathy
Sérgio Nuno Craveiro Barra1, Pedro Gomes, António Leitão Marques
1Cardiology Department, Coimbra Hospital and University Centre, Coimbra, Portugal. sergioncbarra@gmail.com
Insights
Severe lactose intolerance can complicate cardiovascular treatment, leading to gastrointestinal issues with prescribed medications. Managing this requires personalized therapeutic strategies to ensure patient adherence and recovery.
Area of Science:
- Cardiology
- Gastroenterology
- Clinical Pharmacology
Background:
- Coronary artery disease management involves multiple medications, often with excipients.
- Lactose is a common excipient in pharmaceutical formulations.
- Severe lactose intolerance presents unique challenges in medication adherence.
Observation:
- A 72-year-old male with severe lactose intolerance experienced recurrent gastrointestinal distress post-myocardial infarction despite dietary lactose avoidance.
- Symptoms were linked to prescribed cardiovascular medications, suggesting lactose-containing excipients.
- Standard management failed to resolve the patient's gastrointestinal and cardiovascular issues.
Findings:
- Lactose intolerance can significantly impact the therapeutic regimen for cardiovascular diseases.
- Excipient-induced gastrointestinal symptoms can mimic or exacerbate underlying conditions.
- Personalized medication strategies, including alternative formulations or excipients, are crucial.
Implications:
- Healthcare providers must consider lactose intolerance when prescribing medications for cardiac patients.
- Further research is needed on the prevalence and management of lactose-induced drug intolerance.
- Developing lactose-free formulations for essential cardiovascular drugs is a clinical necessity.
Abstract:
A 72-year-old man with severe lactose intolerance was admitted for non-ST-segment elevation myocardial infarction. The coronary angiogram revealed occlusion of the distal third of the first diagonal artery and several non-significant lesions. The pre-discharge echocardiogram revealed moderate left ventricular systolic dysfunction. Discharged on dual antiplatelet therapy, rosuvastatin, perindopril and carvedilol, he was repeatedly readmitted in the following days for abdominal pain/bloating, diarrhea and nausea despite avoiding food products containing lactose. To date, there has been no comprehensive study on the relationship between lactose intolerance and coronary disease, nor has its impact on therapeutics been appropriately addressed. Intolerance to lactose-containing prescription medicines is an extremely rare phenomenon and few strategies are available to overcome this condition, as it has received little attention from the scientific community. Commercial forms of the lactase enzyme and probiotics can limit symptom severity, but different routes of administration, different brands of the same medicine or completely different medicines may be necessary. Some measures were proposed to our patient and, soon afterwards, he was completely asymptomatic in both gastrointestinal and cardiovascular terms.
More Related Videos
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Cardiomyopathy VI: Nursing Management
Myocarditis I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Cardiomyopathy IV: Restrictive Cardiomyopathy

